Owlstone Medical and Cancer Research UK Cambridge Centre Early Detection Programme initiate Pan-Cancer clinical trial to evaluate breath biopsy for early detection of disease

Published: 22nd August, 2018

Trial aims to identify breath biomarkers to improve the early detection and diagnosis of different cancer types.

Owlstone Medical, a diagnostics company developing a breathalyzer for disease, will run the PAN Cancer trial for Early Detection of Cancer in Breath. The large scale clinical study will evaluate the use of Owlstone Medical’s Breath Biopsy® platform for the early detection of multiple cancer types.

Mutations in blood identify individuals at high risk of developing leukaemia

Published: 01st August, 2018

New study reveals that it is possible to identify people at high risk of developing Acute Myeloid Leukaemia (AML) years before they became ill.

Rosetrees Trust Interdisciplinary Prize for early detection of renal cell carcinoma

Published: 30th July, 2018

Successful application to Rosetrees Trust Interdisciplinary Prize 2018 for non-invasive diagnostic test for renal cell cancers at point of care.

Poster prize awarded at ICSA 2018

Published: 16th July, 2018

The International Cell Senescence Association (ICSA) conference 2018 took place from July 8th-11th in Montreal, Canada and was attended by members of the Munoz-Espin lab. Estela Gonzalez-Gualda, PhD student in the lab, was awarded a poster prize at the conference. Many congratulations Estela.

More accurate detection of prostate cancer is on its way

Published: 03rd July, 2018

Mr Vincent Gnanapragasam and Professor Andrew Flewitt featured on the BBC Look East Evening News of 2 July 2018. They have both been working on new devices to improve accuracy in prostate cancer detection. The coverage shows both tools, the CamProbe and the FBAR which should be safer and more accurate than the current PSA test.

Sorex sensors raises £1.2million

Published: 06th June, 2018

Sorex Sensors, a spin-out from the University of Cambridge Department of Engineering has secured an initial round of investment from Cambridge Enterprise, Cambridge Angels and Cambridge Capital Group. The Film Bulk Acoustic Resonator (FBAR) technology has many applications including in cancer detection. One of these applications in prostate cancer detection was investigated by Professor Flewitt and his team with funding from a CRUK Cambridge Centre Early Detection Programme pump-priming award.

Artificial Intelligence could lead to transformation in early diagnosis of cancer

Published: 22nd May, 2018

In a speech by Teresa May the Government has pledged millions of pounds of funding to develop artificial intelligence able to transform outcomes through early diagnosis of cancer and chronic disease through the Industrial Strategy Grand Challenges.

Industry and charities will work with the NHS to develop algorithms that can use patient data and lifestyle information to warn GPs when a patient should be referred to an oncologist or another specialist. It is estimated that AI could help prevent 22,000 deaths from cancer each year by 2033, and give patients an additional five years of healthy, independent life by 2035.

Was anyone harmed by the recent breast cancer screening scandal?

Published: 21st May, 2018

Dr Stephen John, Senior Lecturer in Philosophy of Public Health, Cambridge University has written about the ethical issues surrounding the recent news that IT errors resulted in women not being invited to their final breast screening appointment. He asks: 'Was anyone harmed by the breast cancer screening scandal?' In this balanced analysis Stephen argues that it all depends which direction you look in - read here

Cancer Research UK launch Early Detection collaboration matcher tool

Published: 08th May, 2018

In order to facilitate applications to their new funding schemes that require inter-institutional and multidisciplinary collaborations, CRUK have developed a "Collaboration Matcher". We would like to see much more representation from Cambridge researchers and encourage you to complete the simple form here, outlining your early detection research interests and your collaboration needs. The responses will be made available immediately to other early detection researchers.

Programme member Juliet Usher-Smith awarded grant to investigate bowel cancer screening

Published: 25th April, 2018

Dr Juliet Usher-Smith, academic general practitioner from the Primary Care Unit (PCU) and member of our programme, has been awarded a grant of almost £65,000 from Bowel Cancer UK and Beating Bowel Cancer. The research will investigate whether people living in England should be invited to take part in the bowel cancer screening programme based on their genes and lifestyle factors, not just based on their age.

Page 3 of 7. 62 Items Found.